Modulation of Cell Signaling Networks after CTLA4 Blockade in Patients with Metastatic Melanoma
Begoña Comin-Anduix, Hooman Sazegar, Thinle Chodon et al. · 2010
Read Modulation of Cell Signaling Networks after CTLA4 Blockade in Patients with Metastatic Melanoma by Begoña Comin-Anduix, Hooman Sazegar, Thinle Chodon et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012711.txt.
Description
Comin-Anduix, Sazegar, Chodon and co-authors tracked cell signalling in melanoma patients given an immune therapy. The treatment blocks CTLA4, a brake on T cells, using an antibody called tremelimumab. Their 2010 study read signal networks in blood cells from patients with melanoma that had spread.
They charted how the networks shifted once the brake was lifted. Those shifts show which immune paths the drug truly wakes in people, as opposed to mice. Such maps help predict who benefits and which second drugs might pair well. Patient samples keep the work close to real care.
Catalog record
| CREATOR | Begoña Comin-Anduix, Hooman Sazegar, Thinle Chodon et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012711